Literature DB >> 28875382

[Tumors of the inner ear and adjacent structures].

J Schittenhelm1.   

Abstract

Tumors of the inner ear and adjacent structures often present with hearing loss, tinnitus and vertigo due to compression of the traversing cranial nerves. More than 90% of the tumors of the inner ear with or without expansion into the cerebellopontine angle are histologically diagnosed as vestibular schwannomas. Less common tumorous lesions include ectopic meningiomas located in the petrous bone, glomus tympanicum paragangliomas or endolymphatic sac tumors (ELST) originating in the vestibular recess. Most tumors are sporadic, but hereditary disorders have to be considered. Bilateral vestibular schwannomas are indicative of neurofibromatosis type 2 and ELST in conjunction with other abdominal tumors indicates von Hippel-Lindau disease. The neuropathological diagnostics and grading guides the subsequent therapy of these mostly benign lesions.

Entities:  

Keywords:  Cranial nerves; ELST; NF2; Neuropathology; VHL

Mesh:

Year:  2017        PMID: 28875382     DOI: 10.1007/s00292-017-0358-x

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  36 in total

1.  DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.

Authors:  Felix Sahm; Daniel Schrimpf; Damian Stichel; David T W Jones; Thomas Hielscher; Sebastian Schefzyk; Konstantin Okonechnikov; Christian Koelsche; David E Reuss; David Capper; Dominik Sturm; Hans-Georg Wirsching; Anna Sophie Berghoff; Peter Baumgarten; Annekathrin Kratz; Kristin Huang; Annika K Wefers; Volker Hovestadt; Martin Sill; Hayley P Ellis; Kathreena M Kurian; Ali Fuat Okuducu; Christine Jungk; Katharina Drueschler; Matthias Schick; Melanie Bewerunge-Hudler; Christian Mawrin; Marcel Seiz-Rosenhagen; Ralf Ketter; Matthias Simon; Manfred Westphal; Katrin Lamszus; Albert Becker; Arend Koch; Jens Schittenhelm; Elisabeth J Rushing; V Peter Collins; Stefanie Brehmer; Lukas Chavez; Michael Platten; Daniel Hänggi; Andreas Unterberg; Werner Paulus; Wolfgang Wick; Stefan M Pfister; Michel Mittelbronn; Matthias Preusser; Christel Herold-Mende; Michael Weller; Andreas von Deimling
Journal:  Lancet Oncol       Date:  2017-03-15       Impact factor: 41.316

2.  Brain invasion in otherwise benign meningiomas does not predict tumor recurrence.

Authors:  Peter Baumgarten; Florian Gessler; Jens Schittenhelm; Marco Skardelly; Dominique S Tews; Christian Senft; Maika Dunst; Lioba Imoehl; Karl H Plate; Marlies Wagner; Joachim P Steinbach; Volker Seifert; Michel Mittelbronn; Patrick N Harter
Journal:  Acta Neuropathol       Date:  2016-07-27       Impact factor: 17.088

3.  SMARCB1 deficiency in tumors from the peripheral nervous system: a link between schwannomas and rhabdoid tumors?

Authors:  Daniela Rizzo; Paul Fréneaux; Hervé Brisse; Camille Louvrier; Delphine Lequin; André Nicolas; Dominique Ranchère; Virginie Verkarre; Anne Jouvet; Christelle Dufour; Christine Edan; Jean-Louis Stéphan; Daniel Orbach; Sabine Sarnacki; Gaëlle Pierron; Béatrice Parfait; Michel Peuchmaur; Olivier Delattre; Franck Bourdeaut
Journal:  Am J Surg Pathol       Date:  2012-07       Impact factor: 6.394

Review 4.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

5.  Characterization of endolymphatic sac tumors and von Hippel-Lindau disease in the International Endolymphatic Sac Tumor Registry.

Authors:  Birke Bausch; Ulrich Wellner; Mathieu Peyre; Carsten C Boedeker; Frederik J Hes; Mariagiulia Anglani; Jose M de Campos; Hiroshi Kanno; Eamonn R Maher; Tobias Krauss; Gabriela Sansó; Marta Barontini; Claudio Letizia; Claudia Hader; Francesca Schiavi; Elisabetta Zanoletti; Carlos Suárez; Christian Offergeld; Angelica Malinoc; Stefan Zschiedrich; Sven Glasker; Serge Bobin; Olivier Sterkers; Patrice Tran Ba Huy; Sophie Giraud; Thera Links; Charis Eng; Giuseppe Opocher; Stephane Richard; Hartmut P H Neumann
Journal:  Head Neck       Date:  2015-07-14       Impact factor: 3.147

6.  Papillary neoplasms (Heffner's tumors) of the endolymphatic sac.

Authors:  J G Batsakis; A K el-Naggar
Journal:  Ann Otol Rhinol Laryngol       Date:  1993-08       Impact factor: 1.547

7.  Management of primary and recurrent endolymphatic sac tumors.

Authors:  Matthew L Carlson; Joshua J Thom; Colin L Driscoll; David S Haynes; Brian A Neff; Michael J Link; George B Wanna
Journal:  Otol Neurotol       Date:  2013-07       Impact factor: 2.311

8.  Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.

Authors:  Arjen H G Cleven; Ghadah A Al Sannaa; Inge Briaire-de Bruijn; Davis R Ingram; Matt van de Rijn; Brian P Rubin; Maurits W de Vries; Kelsey L Watson; Keila E Torres; Wei-Lien Wang; Sjoerd G van Duinen; Pancras C W Hogendoorn; Alexander J Lazar; Judith V M G Bovée
Journal:  Mod Pathol       Date:  2016-03-18       Impact factor: 7.842

Review 9.  Update on Select Benign Mesenchymal and Meningothelial Sinonasal Tract Lesions.

Authors:  Lester D R Thompson; Julie C Fanburg-Smith
Journal:  Head Neck Pathol       Date:  2016-02-01

10.  Management of endolymphatic sac tumors: sporadic cases and von Hippel-Lindau disease.

Authors:  Jérôme Nevoux; Catherine Nowak; Jean-François Vellin; Christine Lepajolec; Olivier Sterkers; Stéphane Richard; Serge Bobin
Journal:  Otol Neurotol       Date:  2014-06       Impact factor: 2.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.